Endocrine Disruptors
Key Topics
- Impact of the EU’s Green Deal
- ED Regulation: Regional Specifics
- Study Requirements
- Impact on CLP
- NAMs – Experiences so far
Presenting Institutions and Companies
- Jordane Wodli, European Commission
- Maristella Rubbiani, European Commission
- Scott Lynn, PhD, US EPA
- Kunihiko Yamazaki, Ministry of the Environment, Government of Japan
- Dr Christian Unkelbach, Federal Office for Chemicals (BfC), Federal Institute for Occupational Safety and Health (BAuA), Germany
- Dr Philip Marx-Stölting, BfR German Federal Institute for Risk Assessment
- Prof Dr Lennart Weltje, BASF SE, Germany
- Dr Volker J. Soballa, Evonik Industries AG, Germany
- Dr Natalie Burden, NC3Rs, United Kingdom
- Dr Melanie Lichtenberger, ibacon GmbH, Germany
- Dr Christian Kirchnawy, OFI Technologie & Innovation GmbH, Austria
- Dr James Wheeler, Corteva Agriscience, The Netherlands
- Andy Adams, PhD, FleishmanHillard, France
- Dr Heli Hollnagel, Dow Europe / The Dow Chemical Company, Switzerland
- Jelena Buha, PhD, Zurich Insurance Group Ltd, Switzerland
- Zanda Romata, Partner, Avocat, Barrister, Steptoe LLP, Belgium